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• Cystic Fibrosis Related Diabetes (CFRD) is the commonest comorbidity in CF leading to increased mortality rates • CFRD is associated with reduced lung function and poor nutritional status • The pathophysiology includes pancreatic fibrosis, reduction in αcell and ßcell mass, delayed insulin secretion and variable insulin insensitivity. Insulin production can fluctuate with progression over time to an insulinopenic state 1 ( figure 1 (1.5 units/kg/day) • Initial improvement in BG control was followed by issues with adherence to insulin injections, low mood and suicide attempt • Three and a half years after diagnosis a decision was taken to support her request to start insulin pump therapy • Commenced insulin pump therapy (0.74 units/kg/day) • Highly motivated in using pump therapy • Overall engagement with CF MDT improved, however some ongoing non-compliance with CF treatment
Case 1 comments "First of all I had injections, but I had to have so many of them that they just thought I should just go on an insulin pump instead" "The pump makes me feel better…I think it's much better to be on the pump because now I don't have to have any injections"
Case 2 comments "I take insulin with everything I eat, but I'm on an insulin pump so I don't have to do any injections" "I type in my blood sugar level and then the number of carbs I'm eating then I press a button and it delivers the insulin…It makes me feel a lot better" "The transformation was dramatic…she didn't have to think about insulin which had removed a great burden" (Clinical psychologist)
Discussion
• These cases show that young people with CFRD can present in an insulinopenic state requiring as much insulin as a young person with Type 1 diabetes • Children and young people with CF require a high calorie diet, with multiple meals and snacks. Therefore multiple injections are required to achieve euglycaemia in CFRD 4 • Limiting carbohydrate intake or omitting insulin can effect nutritional status and growth. An insulin pump gives the ability to give insulin without multiple injections 4 • When managing CFRD the goal of treatment is not necessarily reduction in HbA1c but supporting the young person to manage the burden of a second chronic disease • In a cohort of patients with CFRD, insulin pump therapy has the potential to give these children and young people the best quality of life alongside improved glycaemic control • HbA1c improvement was seen at 6 months despite a reduction in insulin requirements • The greatest improvement was seen in psychological wellbeing and subsequent engagement with all treatments
